Selected research
Industry Growth & Trends
Global Mycology Immunoassays Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Mycology Immunoassays Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Mycology Immunoassays Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Mycology Immunoassays Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mycology Immunoassays Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Mycology Immunoassays Testing market include Abbott, Roche, CapitalBio Corporation, Autobio Diagnostics CO.,Ltd., Siemens, Ortho-Clinical Diagnostics, MiraVista Diagnostics, ELITechGroup and bioMérieux, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Mycology Immunoassays Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Mycology Immunoassays Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mycology Immunoassays Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mycology Immunoassays Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Mycology Immunoassays Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Mycology Immunoassays Testing Market by Company
Abbott
Roche
CapitalBio Corporation
Autobio Diagnostics CO.,Ltd.
Siemens
Ortho-Clinical Diagnostics
MiraVista Diagnostics
ELITechGroup
bioMérieux
Beckman Coulter
Mycology Immunoassays Testing Segment by Type
ELISA
ELISPOT
Polymerase Chain Reaction (PCR)
Rapid Tests
Mycology Immunoassays Testing Segment by Application
Hospitals
Blood Banks
Others
Mycology Immunoassays Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycology Immunoassays Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mycology Immunoassays Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycology Immunoassays Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Mycology Immunoassays Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- ELISA
- ELISPOT
- Polymerase Chain Reaction (PCR)
- Rapid Tests
Applications
- Hospitals
- Blood Banks
- Others
Companies covered
- Abbott
- Roche
- CapitalBio Corporation
- Autobio Diagnostics CO.,Ltd.
- Siemens
- Ortho-Clinical Diagnostics
- MiraVista Diagnostics
- ELITechGroup
- bioMérieux
- Beckman Coulter
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Mycology Immunoassays Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Mycology Immunoassays Testing Market Size by Region (2021-2032)
- 1.4.1 Global Mycology Immunoassays Testing Market Size by Region (2021-2026)
- 1.4.2 Global Mycology Immunoassays Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Mycology Immunoassays Testing Market Size (2021-2032)
- 1.5.1 North America Mycology Immunoassays Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Mycology Immunoassays Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Mycology Immunoassays Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Mycology Immunoassays Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Mycology Immunoassays Testing Market Size Growth Rate (2021-2032)
2 Mycology Immunoassays Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 ELISA
- 2.1.2 ELISPOT
- 2.1.3 Polymerase Chain Reaction (PCR)
- 2.1.4 Rapid Tests
- 2.2 Global Mycology Immunoassays Testing Market Size by Type
- 2.2.1 Global Mycology Immunoassays Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Mycology Immunoassays Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Mycology Immunoassays Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Mycology Immunoassays Testing Market Size by Regions
- 2.3.1 North America Mycology Immunoassays Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Mycology Immunoassays Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Mycology Immunoassays Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Mycology Immunoassays Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Mycology Immunoassays Testing Market Size Breakdown by Type (2021-2026)
3 Mycology Immunoassays Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Blood Banks
- 3.1.3 Others
- 3.2 Global Mycology Immunoassays Testing Market Size by Application
- 3.2.1 Global Mycology Immunoassays Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Mycology Immunoassays Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Mycology Immunoassays Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Mycology Immunoassays Testing Market Size by Regions
- 3.3.1 North America Mycology Immunoassays Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Mycology Immunoassays Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Mycology Immunoassays Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Mycology Immunoassays Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Mycology Immunoassays Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Mycology Immunoassays Testing Industry Trends
- 4.2 Mycology Immunoassays Testing Industry Drivers
- 4.3 Mycology Immunoassays Testing Industry Opportunities and Challenges
- 4.4 Mycology Immunoassays Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Mycology Immunoassays Testing Revenue (2021-2026)
- 5.2 Global Mycology Immunoassays Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Mycology Immunoassays Testing Key Company Headquarters & Area Served
- 5.4 Global Mycology Immunoassays Testing Company, Product Type & Application
- 5.5 Global Mycology Immunoassays Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Mycology Immunoassays Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Mycology Immunoassays Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Mycology Immunoassays Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abbott Mycology Immunoassays Testing Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Roche Mycology Immunoassays Testing Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 CapitalBio Corporation
- 6.3.1 CapitalBio Corporation Company Information
- 6.3.2 CapitalBio Corporation Business Overview
- 6.3.3 CapitalBio Corporation Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 CapitalBio Corporation Mycology Immunoassays Testing Product Portfolio
- 6.3.5 CapitalBio Corporation Recent Developments
- 6.4 Autobio Diagnostics CO.,Ltd.
- 6.4.1 Autobio Diagnostics CO.,Ltd. Company Information
- 6.4.2 Autobio Diagnostics CO.,Ltd. Business Overview
- 6.4.3 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Product Portfolio
- 6.4.5 Autobio Diagnostics CO.,Ltd. Recent Developments
- 6.5 Siemens
- 6.5.1 Siemens Company Information
- 6.5.2 Siemens Business Overview
- 6.5.3 Siemens Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Siemens Mycology Immunoassays Testing Product Portfolio
- 6.5.5 Siemens Recent Developments
- 6.6 Ortho-Clinical Diagnostics
- 6.6.1 Ortho-Clinical Diagnostics Company Information
- 6.6.2 Ortho-Clinical Diagnostics Business Overview
- 6.6.3 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Product Portfolio
- 6.6.5 Ortho-Clinical Diagnostics Recent Developments
- 6.7 MiraVista Diagnostics
- 6.7.1 MiraVista Diagnostics Company Information
- 6.7.2 MiraVista Diagnostics Business Overview
- 6.7.3 MiraVista Diagnostics Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 MiraVista Diagnostics Mycology Immunoassays Testing Product Portfolio
- 6.7.5 MiraVista Diagnostics Recent Developments
- 6.8 ELITechGroup
- 6.8.1 ELITechGroup Company Information
- 6.8.2 ELITechGroup Business Overview
- 6.8.3 ELITechGroup Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 ELITechGroup Mycology Immunoassays Testing Product Portfolio
- 6.8.5 ELITechGroup Recent Developments
- 6.9 bioMérieux
- 6.9.1 bioMérieux Company Information
- 6.9.2 bioMérieux Business Overview
- 6.9.3 bioMérieux Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 bioMérieux Mycology Immunoassays Testing Product Portfolio
- 6.9.5 bioMérieux Recent Developments
- 6.10 Beckman Coulter
- 6.10.1 Beckman Coulter Company Information
- 6.10.2 Beckman Coulter Business Overview
- 6.10.3 Beckman Coulter Mycology Immunoassays Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Beckman Coulter Mycology Immunoassays Testing Product Portfolio
- 6.10.5 Beckman Coulter Recent Developments
7 North America
- 7.1 North America Mycology Immunoassays Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 7.3 North America Mycology Immunoassays Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Mycology Immunoassays Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 8.3 Europe Mycology Immunoassays Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Mycology Immunoassays Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Mycology Immunoassays Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Mycology Immunoassays Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 10.3 South America Mycology Immunoassays Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Mycology Immunoassays Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Mycology Immunoassays Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst